Prof Franco Odicino, MD, PhD is an expert in Gynecology at Spedali Civili di Brescia (Italy). Franco Odicino has authored 204 publications, the most recent in 2026, and is an investigator in 5 clinical trials, 1 of them ongoing. SLR score: 653 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Franco Odicino, MD, PhD Spedali Civili di Brescia Italy
653 ScienceLeadR Reputation 653
Network Map

Gynecology

Subspecialties: Obstetrics - Oncology - Surgery

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2001 - 2026

Source: PubMed

University of Brescia

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 204

Citations

Citations: 12 390 1st author: 6 Last author: 53 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Abstracts of the 36th World Congress on Ultrasound in Obstetrics and Gynecology, 4-7 September 2026, London, UK.
PMID 42672646 — ultrasonography, obstetrics, ultrasonography, prenatal, gynecology
Ultrasound Obstet Gynecol20260
Case Report: Persistent urogenital sinus (PUGS) associated with complete bicorporeal uterus, double cervix and partial longitudinal non-obstructing vaginal septum: a one-stop diagnostic and operative hysteroscopic approach.
PMID 42661764 — uterus, hysteroscopy, vagina, cervix uteri, uterine duplication anomalies
Front Surg20260
Maternal First Trimester SIMPLE Nutritional Score and Intrauterine Fetal Growth Trajectory: A Prospective Multicenter Italian study (SIMPLE study).
PMID 42087268 — pregnancy trimester, first, growth, pregnancy trimester, third, sex, nutritional status, nutritional physiological phenomena
Br J Nutr20260
Decoding BRCA1 and BRCA2 Mutations in High-Grade Serous Ovarian Cancer: Impact of Location and Type of Mutation on Prognosis and PARP Inhibitor Treatment.
PMID 42061278 — poly(adp-ribose) polymerase inhibitors, ovary, neoplasms, multiple chronic conditions, ribose, adenosine, ovarian neoplasms, adenosine diphosphate, therapeutics, genes, brca2, genes, brca1, mutation, prognosis
Int J Gynecol Cancer20260
Long COVID following SARS-CoV-2 infection during pregnancy: An observational study in a large Italian hospital during the COVID-19 pandemic.
PMID 41685877 — pregnant women, comorbidity, pregnancy, sars-cov-2, vaccines, obstetrics, vaccination, signs and symptoms, covid-19, pneumonia, gynecology, risk factors, pandemics, severe acute respiratory syndrome-related coronavirus, infections, post-acute covid-19 syndrome
Acta Obstet Gynecol Scand20260

Clinical Studies 5

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 5

By status:

Unknown 3
Completed 1
Recruiting 1

By type:

Observational 3
Interventional 2

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 1
multicentric5to9 0
multicentricup10 0

Main Topics

Cohort/Consortium Investigators 2

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Adherence and Compliance to ERAS in Gynecological Surgery
NCT05738902 — pain, uterine cervical neoplasms, ovary, genital neoplasms, female, neoplasms, gynecologic surgical procedures, ovarian neoplasms, uterine neoplasms, postoperative complications, pain, postoperative, endometrial neoplasms, cervix uteri, female
N/ARecruiting2023

LeadR Networks

Main global connection map